452 related articles for article (PubMed ID: 3582746)
61. The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells.
Heilmann K; Groth T; Behrsing O; Albrecht W; Schossig M; Lendlein A; Micheel B
J Biotechnol; 2005 Feb; 115(3):291-301. PubMed ID: 15639091
[TBL] [Abstract][Full Text] [Related]
62. A perfusion system for high productivity of monoclonal antibody by hybridoma cells in a CelliGen bioreactor.
Chen Y
Chin J Biotechnol; 1992; 8(3):179-86. PubMed ID: 1295598
[TBL] [Abstract][Full Text] [Related]
63. A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: effect of nutrient concentration, dilution rate, and pH. Reprinted from Biotechnology and Bioengineering, Vol. 32, Pp 947-965 (1988).
Miller WM; Blanch HW; Wilke CR
Biotechnol Bioeng; 2000 Mar; 67(6):853-71. PubMed ID: 10699863
[TBL] [Abstract][Full Text] [Related]
64. Metabolic activity and monoclonal antibody production of Salmonella enteritidis O and H antigen specific hybridoma cells in static culture.
Nalbantsoy A; Bora K; Deliloglu-Gurhan I
Hybridoma (Larchmt); 2011 Apr; 30(2):189-93. PubMed ID: 21529293
[TBL] [Abstract][Full Text] [Related]
65. Monoclonal antibody production in dialyzed continuous suspension culture.
Linardos TI; Kalogerakis N; Behie LA; Lamontagne LR
Biotechnol Bioeng; 1992 Mar; 39(5):504-10. PubMed ID: 18600976
[TBL] [Abstract][Full Text] [Related]
66. Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production.
Ozturk SS; Riley MR; Palsson BO
Biotechnol Bioeng; 1992 Feb; 39(4):418-31. PubMed ID: 18600963
[TBL] [Abstract][Full Text] [Related]
67. Biochemistry of hybridoma technology.
Wilson R; Spier RE
Dev Biol Stand; 1987; 66():161-7. PubMed ID: 3582745
[TBL] [Abstract][Full Text] [Related]
68. Optimal nitrogen supply as a key to increased and sustained production of a monoclonal full-size antibody in BY-2 suspension culture.
Holland T; Sack M; Rademacher T; Schmale K; Altmann F; Stadlmann J; Fischer R; Hellwig S
Biotechnol Bioeng; 2010 Oct; 107(2):278-89. PubMed ID: 20506104
[TBL] [Abstract][Full Text] [Related]
69. A comparison of different culture methods for hybridoma propagation and monoclonal antibody production.
Marquis CP; Harbour C; Barford JP; Low KS
Cytotechnology; 1990 Jul; 4(1):69-76. PubMed ID: 1366723
[TBL] [Abstract][Full Text] [Related]
70. Large-scale production of monoclonal antibodies in defined serum-free media in airlift bioreactors.
Petrossian A; Cortessis GP
Biotechniques; 1990 Apr; 8(4):414-22. PubMed ID: 2340179
[TBL] [Abstract][Full Text] [Related]
71. Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity.
Tey BT; Al-Rubeai M
Apoptosis; 2004 Nov; 9(6):843-52. PubMed ID: 15505426
[TBL] [Abstract][Full Text] [Related]
72. Molecular integrity of monoclonal antibodies produced by hybridoma cells in batch culture and in continuous-flow culture with integrated product recovery.
Mohan SB; Chohan SR; Eade J; Lyddiatt A
Biotechnol Bioeng; 1993 Oct; 42(8):974-86. PubMed ID: 18613146
[TBL] [Abstract][Full Text] [Related]
73. Medium-scale production and purification of monoclonal antibodies in protein-free medium.
Tarleton RL; Beyer AM
Biotechniques; 1991 Nov; 11(5):590-3. PubMed ID: 1804247
[TBL] [Abstract][Full Text] [Related]
74. Enhanced antibody production following intermediate addition based on flux analysis in mammalian cell continuous culture.
Omasa T; Furuichi K; Iemura T; Katakura Y; Kishimoto M; Suga K
Bioprocess Biosyst Eng; 2010 Jan; 33(1):117-25. PubMed ID: 19590901
[TBL] [Abstract][Full Text] [Related]
75. Ammonia inhibition of hybridomas propagated in batch, fed-batch, and continuous culture.
Newland M; Kamal MN; Greenfield PF; Nielsen LK
Biotechnol Bioeng; 1994 Mar; 43(5):434-8. PubMed ID: 18615727
[TBL] [Abstract][Full Text] [Related]
76. Metabolic engineering of animal cells.
Häggström L; Ljunggren J; Ohman L
Ann N Y Acad Sci; 1996 May; 782():40-52. PubMed ID: 8659912
[TBL] [Abstract][Full Text] [Related]
77. Tissue culture in hollow-fibre systems: implications for downstream processing and stability analysis.
Tiebout RF
Dev Biol Stand; 1990; 71():65-71. PubMed ID: 2119319
[TBL] [Abstract][Full Text] [Related]
78. Modeling kinetics of a large-scale fed-batch CHO cell culture by Markov chain Monte Carlo method.
Xing Z; Bishop N; Leister K; Li ZJ
Biotechnol Prog; 2010; 26(1):208-19. PubMed ID: 19834967
[TBL] [Abstract][Full Text] [Related]
79. Process-scale purification from cell culture supernatants: monoclonal antibodies.
Ostlund C; Borwell P; Malm B
Dev Biol Stand; 1987; 66():367-75. PubMed ID: 3108053
[TBL] [Abstract][Full Text] [Related]
80. High-end pH-controlled delivery of glucose effectively suppresses lactate accumulation in CHO fed-batch cultures.
Gagnon M; Hiller G; Luan YT; Kittredge A; DeFelice J; Drapeau D
Biotechnol Bioeng; 2011 Jun; 108(6):1328-37. PubMed ID: 21328318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
